AMHD OTC
HLK Biotech Holding Group, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -0.0%
3Y: +100.0%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000199999995-0.013
Volume2,500
Avg Volume2,143
Beta0.98
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAnna Petinova
Employees5
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1999-02-11
Websiteamelotholdings.com
2612 Granby Street
Norfolk, VA 23517
US
Norfolk, VA 23517
US
646-926-3568
About HLK Biotech Holding Group, Inc.
HLK Biotech Holding Group, Inc. operates primarily through its various subsidiaries, focusing on the production and distribution of biodiesel. In addition to its energy sector activities, the company also engages in the acquisition of real estate assets. The firm was formerly recognized as Amelot Holdings, Inc., but it officially rebranded to HLK Biotech Holding Group, Inc. in February 2018. The company's principal office is located in Norfolk, Virginia.
Latest News
No recent news
Recent Insider Trades
No insider trades found